Na+-V-ATPase抑制剂抑制了VRE的生长,并揭示了Na+通路结构
Kano Suzuki1,2,3, Yoshiyuki Goto3,4,5,6,7, Akihiro Otomo8,9
1Department of Chemistry, Graduate School of Science, Chiba University, Chiba, Japan.
Nature structural & molecular biology
|November 21, 2024
概括
一种新的化合物V-161通过向它的V-ATPase.有效地抑制了抗万科胺素的Enterococcus faecium (VRE) 的生长和殖民. 这一发现为对抗VRE感染提供了一个有希望的策略.
科学领域:
- 微生物学 微生物学
- 生物化学 生物化学
- 结构生物学 结构生物学
背景情况:
- 抗万科米辛的菌 (Enterococcus faecium,VRE) 是导致医院感染的重要原因之一.
- 现有的抗生素对VRE的疗效越来越低,需要新的治疗策略.
- Enterococcus物种中的Na+运输V-ATPase在细胞功能中起着至关重要的作用,特别是在性条件下.
研究的目的:
- 为了确定VRE生长的新型抑制剂.
- 研究已识别的抑制剂的作用机制.
- 阐明V-ATPase抑制的结构基础.
主要方法:
- 化合物库 (70,600种化合物) 的高通量选,以识别V-ATPase抑制剂.
- 在体外测试以评估V-ATPase活性抑制和VRE生长.
- 在体内研究以评估VRE殖民抑制在小鼠模型.
- 高分辨率结构分析V-ATPase VO域与抑制剂复合.
主要成果:
- 化合物V-161被确定为Enterococcus hirae V-ATPase活性的一个强有力的抑制剂.
- 在性条件下,V-161显著抑制了VRE生长.
- V-161显著抑制了小鼠小肠中的VRE殖民.
- 高分辨率结构揭示了V-161在c环和a子单元的接口上结合,阻止Na+运输和旋转.
结论:
- V-161是一种有前途的化合物,用于开发新的抗VRE疗法.
- 准运输Na+的V-ATPase是对抗VRE感染的可行策略.
- 对V-161结合的结构洞察力为针对VRE的合理药物设计提供了基础.
更多相关视频
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
10.0K
09:16In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity
Published on: March 25, 2020
7.2K
相关概念视频
ATP Driven Pumps III: V-type Pumps
3.6K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.6K
Pinching-off of Coated Vesicles
3.1K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
3.1K
ATP Synthase: Mechanism
13.9K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.9K
Rab Proteins
3.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.9K
